|4Dec 2, 4:14 PM ET

Jin David 4

4 · Fortress Biotech, Inc. · Filed Dec 2, 2022

Insider Transaction Report

Form 4
Period: 2022-11-30
Jin David
Chief Financial Officer
Transactions
  • Purchase

    COMMON STOCK, PAR VALUE $0.001

    2022-11-30$0.56/sh+5,000$2,8001,402,829 total
Footnotes (2)
  • [F1]Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period. Under the ESPP, 5,000 shares is the maximum amount an individual employee may purchase during an offering period.
  • [F2]The total holdings include 1,350,000 shares underlying restricted stock units.

Documents

1 file
  • 4
    tm2231877-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT